Company: IXHL
Filing Date: 2025-04-07
Form Type: 424B5
Source: 0001213900-25-029414
Chunk: 41

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-07
Form: 424B5
Chunk 41
---
 
 development of our drug candidates and our ability to continue as a going concern;        |

| ● | our                                                                                        
 ability to comply with the provisions and requirements of our debt arrangements and to pay 
 amounts owed, including any amounts that may be accelerated;                               |

<div align='center'>4</div>

| ● | our                                                                                     
 ability to retain and attract qualified employees, directors, consultants and advisors; |

| ● | our                                                                                             
 ability to continue to comply with applicable privacy laws and protect confidential information 
 from security breaches;                                                                         |

| ● | how                                                                                           
 recent and potential future changes in healthcare policy could negatively impact our business 
 and financial condition;                                                                      |

| ● | the                                                                                                
 extent to which global economic and political developments, including existing regional conflicts, 
 pandemics, natural disasters, and the indirect and/or long-term impact of inflation, will          
 affect our business operations, clinical trials, or financial condition; and                       |

| ● | any                                                       
 statement of assumptions underlying any of the foregoing. |

Although forward-looking statements in this prospectus supplement and the accompanying prospectus, including the documents incorporated by reference herein and therein, and in any free writing prospectus that we have authorized for use in connection with this offering, reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the heading “Risk Factors” contained in this prospectus supplement, the accompanying prospectus and any related free writing prospectus, and under similar headings in the other documents that are incorporated by reference into this prospectus supplement and the accompanying prospectus, including our most recent annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as well as any amendments thereto reflected in subsequent filings with the SEC. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date made. We file reports with the SEC, and our electronic filings with the SEC (including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and any amendments to these reports) are available free of charge on the SEC’s website at http://www.sec.gov.

We undertake no obligation to revise or update any